Topic
User Fees
40 published works
Canada-U.S. Blog
Controlled Goods Program To Undergo Changes in 2014 – Consultations Underway
in November 2013, Canada's Public Works and Government Services Canada (PWGSC) announced consultations concerning the implementation user fees in connection with the Controlled Goods Program (CGP). The Controlled Goods Program…
Focus on Regulation
FDA Activities During Government Shutdown
By Lynn Mehler, Marie A. Vodicka
The U.S. Food and Drug Administration staff will continue User Fee supported activities and vital consumer protection activities during the government shutdown. FDA staff, including review divisions and chief counsel’s…
Biosimilars Law Blog
FDA Activities During Government Shutdown
By Lynn Mehler, Marie A. Vodicka
The U.S. Food and Drug Administration staff will continue User Fee supported activities and vital consumer protection activities during the government shutdown. FDA staff, including review divisions and chief counsel’s…
Global Regulatory Enforcement Law Blog
A River Runs Through It: Congress finds a potential way to fund water infrastructure projects despite sequestration
By Christopher L. Rissetto, Robert Helland
The Senate Environment and Public Works Committee (“EPW”) marked up legislation Wednesday that provides millions for dredging, hurricane risk reduction and environmental restoration projects. Normally, Congress providing funds for water…
Health Industry Washington Watch
Short-Term Government Funding, FDA User Fee & Safe Doses Bills Signed into Law
President Obama has signed into law a temporary spending bill (H.J.Res. 117) to fund the government until March 27, 2013 in light of Congress’ failure to reach agreement on the…
Triage Health Law
No Shortage of Changes in FDA’s User Fee Bill
On June 27, 2012, the U.S. Senate passed (by a vote of 92-4) the Food and Drug Administration Safety and Innovation Act, a bill primarily designed to let the U.S.…
Health Industry Washington Watch
House, Senate Approve FDA User Fee/Drug Safety Bills
On May 30, 2012, the House of Representatives voted 387-5 to approve H.R. 5651, the Food and Drug Administration Reform Act. The House bill would reauthorize the Prescription Drug User Fee…
Health Industry Washington Watch
House Panel Unanimously Approves FDA User Fee Act
On May 10, 2012, the House Energy and Commerce Committee unanimously approved H.R. 5651, the Food and Drug Administration Reform Act. The legislation would reauthorize the Prescription Drug User Fee…
Health Industry Washington Watch
April Congressional Health Policy Hearings and Markups
The House Energy and Commerce Committee Health Subcommittee recently held a hearing on “FDA User Fees 2012: How Innovation Helps Patients and Jobs,” focusing on reauthorization of the Prescription Drug…
Health Care and Life Sciences
FDA Announces Proposals for Biosimilars User Fees and Performance Review Goals
By Peter Reichertz FDA has at last began formal implementation of the Biologics Price Competition and Innovation Act of 2009 ("BPCI Act"), by announcing the proposal it will send to…